BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23751135)

  • 21. Role of semi-quantitative dynamic contrast-enhanced MR imaging in characterization and grading of prostate cancer.
    Kim SH; Choi MS; Kim MJ; Kim YH; Cho SH
    Eur J Radiol; 2017 Sep; 94():154-159. PubMed ID: 28712703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach.
    Winkel DJ; Breit HC; Block TK; Boll DT; Heye TJ
    Eur Radiol; 2020 Sep; 30(9):4828-4837. PubMed ID: 32328763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].
    Baccos A; Schiavina R; Zukerman Z; Busato F; Gaudiano C; Salizzoni E; Fiorentino M; Golfieri R; Martorana G
    Urologia; 2012; 79(2):116-22. PubMed ID: 22522463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.
    Peng Y; Jiang Y; Yang C; Brown JB; Antic T; Sethi I; Schmid-Tannwald C; Giger ML; Eggener SE; Oto A
    Radiology; 2013 Jun; 267(3):787-96. PubMed ID: 23392430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard.
    Gibbons M; Simko JP; Carroll PR; Noworolski SM
    Magn Reson Imaging; 2023 Jun; 99():48-57. PubMed ID: 36641104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.
    Ream JM; Doshi AM; Dunst D; Parikh N; Kong MX; Babb JS; Taneja SS; Rosenkrantz AB
    J Magn Reson Imaging; 2017 May; 45(5):1464-1475. PubMed ID: 27649481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics.
    Wildeboer RR; Mannaerts CK; van Sloun RJG; Budäus L; Tilki D; Wijkstra H; Salomon G; Mischi M
    Eur Radiol; 2020 Feb; 30(2):806-815. PubMed ID: 31602512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
    Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
    Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis.
    Junker D; Quentin M; Nagele U; Edlinger M; Richenberg J; Schaefer G; Ladurner M; Jaschke W; Horninger W; Aigner F
    World J Urol; 2015 Jul; 33(7):1023-30. PubMed ID: 25081011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
    Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
    Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
    Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
    Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
    Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
    Lang N; Yuan H; Yu HJ; Su MY
    Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.